Invitae (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Invitae" in English language version.

refsWebsite

Global rank English rank

4web.archive.org

1^st place

4invitae.com

low place

1xconomy.com

low place

6,978^th place

1mddionline.com

low place

1investors.com

low place

6,516^th place

1nasdaq.com

2,740^th place

2,050^th place

1streetinsider.com

low place

1nytimes.com

7^th place

1medgadget.com

low place

1sec.gov

572^nd place

436^th place

1wsj.com

79^th place

65^th place

1investorplace.com

low place

1bloomberglaw.com

5,670^th place

3,086^th place

1reuters.com

49^th place

47^th place

bloomberglaw.com

news.bloomberglaw.com

"SoftBank backed genetic test firm Invitae files for Chapter 11". Bloomberg Law. February 13, 2024. Retrieved February 14, 2024.

investorplace.com

Pan, Eddie (2024-02-06). "The New York Stock Exchange Will Start Delisting Invitae (NVTA) Stock". InvestorPlace. Retrieved 2024-02-06.

investors.com

Gatlin, Allison (2020-06-22). "Genetic Testing Behemoth Invitae Rockets 45% On $1.4 Billion Acquisition". investors.com. Archived from the original on 2020-06-23. Retrieved 2021-01-30.

invitae.com

ir.invitae.com

"Invitae Announces Leadership Transition". 18 July 2022.
"Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research". ir.invitae.com. Retrieved 2021-10-07.
"Invitae Enters into Agreement with Labcorp for Sale of Business". Invitae. 24 April 2024.

invitae.com

"Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life". Invitae. 2017-08-03. Archived from the original on 2021-01-30. Retrieved 2021-01-30.

mddionline.com

Pedersen, Amanda (2017-08-01). "Invitae is Going After Prenatal Screening in a Big Way". MDDIonline.com. Archived from the original on 2021-01-30.

medgadget.com

"Chromosomal Microarrays for Prenatal Testing: Interview with CombiMatrix CEO Mark McDonough". medgadget.com. 18 August 2014. Retrieved 30 October 2014.

nasdaq.com

"Sector Update: Health Care Stocks Ending in Deep Hole; CombiMatrix Climbs Off All-Time Lows After Reporting Big Growth in Testing Volumes". nasdaq.com. Retrieved 13 October 2014.

nytimes.com

topics.nytimes.com

"CombiMatrix Corporation". The New York Times. Retrieved 30 October 2014.

reuters.com

"CombiMatrix Corp 's Pediatric development disorders analysis test granted conditional approval from New York State Department of Health". reuters.com. Retrieved 30 October 2014.

sec.gov

"Form 10-K (2008)". SEC.gov. Retrieved 2020-01-30.

streetinsider.com

"CombiMatrix (CBMX) Sees Record Prenatal Testing Volumes in Q314". streetinsider.com. Retrieved 13 October 2014.

web.archive.org

Lash, Alex (20 October 2015). "What's Your DNA Worth? The Scramble To Cash In On the Genome". exome. Archived from the original on 2015-10-21. Retrieved 10 January 2017.
"Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life". Invitae. 2017-08-03. Archived from the original on 2021-01-30. Retrieved 2021-01-30.
Pedersen, Amanda (2017-08-01). "Invitae is Going After Prenatal Screening in a Big Way". MDDIonline.com. Archived from the original on 2021-01-30.
Gatlin, Allison (2020-06-22). "Genetic Testing Behemoth Invitae Rockets 45% On $1.4 Billion Acquisition". investors.com. Archived from the original on 2020-06-23. Retrieved 2021-01-30.

wsj.com

"SoftBank-Backed Medical Genetics Company Invitae Prepares for Bankruptcy". The Wall Street Journal. 2024-02-05.

xconomy.com

Lash, Alex (20 October 2015). "What's Your DNA Worth? The Scramble To Cash In On the Genome". exome. Archived from the original on 2015-10-21. Retrieved 10 January 2017.